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Background: The aim of this study is to compare three methodologies of prostate localization and to determine if
there are significant differences in the techniques.
Methods: Daily prostate localization using cone beam CT or orthogonal kV imaging has been performed at UT
Southwestern Medical Center since 2006. Prostate patients are implanted with gold seeds, which are matched with
the planning CT or DRR before treatment. More recently, a technology using electromagnetic transponders
implanted within the prostate was introduced into our clinic (CalypsoW). With each technology, patients are
localized initially using skin marks and the room lasers. In this study, patients were localized with Calypso and either
CBCT or kV orthogonal images in the same treatment session, allowing a direct comparison of the technologies.
Localization difference distributions were determined from the difference in the offsets determined by CBCT/kV
imaging and Calypso. CBCT-Calypso and kV imaging-Calypso localization data were summarized from over 900 and
250 fractions each, respectively. The Wilcoxon signed rank test is used to determine if the localization differences
are statistically significant. We also calculated Pearson’s product–moment correlation coefficient (R2) to determine if
there is a linear relationship between the shifts determined by Calypso and the radiographic techniques.
Results: The differences between CBCT-Calypso and kV imaging-Calypso localizations are −0.18 ± 2.90 mm, -0
.79 ± 2.18 mm, -0.01 ± 1.20 mm and −0.09 ± 1.40 mm, 0.48 ± 1.50 mm, 0.08 ± 1.04 mm, respectively, in the AP, SI, and
RL directions. The Pearson product–moment correlation coefficients for the CBCT-Calypso shifts were 0.71, 0.92 and
0.88 and for the OBI-Calypso comparison were 0.95, 0.89 and 0.85. The percentage of localization differences that
were less than 3 mm were 86.1%, 84.5% and 96.0% for the CBCT-Calypso comparison and 95.8%, 94.3% and 97%
for the kV OBI-Calypso comparison. No trends were observed in the Bland-Altman analysis.
Conclusions: Localization of the prostate using electromagnetic transponders agrees well with radiographic
techniques and each technology is suitable for high precision radiotherapy. This study finds that there is more
uncertainty in CBCT localization of the prostate than in 2D orthogonal imaging, but the difference is not clinically
significant.
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One of the greatest challenges in radiation oncology is
the uncertainty of tumor and organ position within the
patient. Computed tomography (CT) scans used for
treatment planning are snapshots of the patient taken
days before treatment begins. In the case of prostate* Correspondence: Ryan.Foster@utsouthwestern.edu
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reproduction in any medium, provided the orcancer, variable filling of the bladder and rectum virtu-
ally guarantee that on the first day of treatment the
prostate will not be in the same position as the day of
the planning CT scan. To account for setup uncertainty
and organ motion, the ICRU[1,2] has recommended that
a margin be added to the target during the planning
process. Unfortunately, the planning target volume
(PTV) often includes healthy tissues or organs that are
irradiated unnecessarily. If the prostate could betd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and more healthy tissue could be spared. Accurate
localization is even more critical for dose escalation and
hypo-fractionation.
Prostate localization has been studied extensively and
several different technologies have been used for daily
localization, including transabdominal ultrasound, X-ray
portal imaging, and kilovoltage and megavoltage cone
beam CT [3-14]. With these technologies, patients are
localized using bony anatomy, implanted fiducials, or
three-dimensional volumetric images. These image-
guided technologies have allowed the therapist to deter-
mine the magnitude and direction of the setup error and
correct for it before treatment is initiated. Numerous
studies have been published describing the merits of the
various methods; in general, localization uncertainties
are on the order of 0.5 cm (1σ) in each direction [6-14].
Prostate localization using implanted markers is increas-
ing in use [7,9-11,14]. After conebeam CT (CBCT) or
kV imaging, the markers are matched to a reference CT
or a digitally reconstructed radiograph (DRR), and a
software algorithm is used to calculate the necessary
couch shifts.
The CalypsoW 4D localization system (Varian Medical
Systems, Palo Alto, CA) is the first localization technol-
ogy to provide completely objective localization as well
as continuous monitoring of the prostate position during
radiation therapy. By utilizing electromagnetic detection
of three transponders implanted in the prostate, Calypso
provides a user- independent method of localizing the
prostate gland in patients.
The purpose of this study is to compare the accuracy
of CBCT, kV imaging and Calypso for localization of the
prostate at a single institution.
Methods and materials
Since 2006, prostate patients in our department have
had gold seeds implanted for the purpose of localization,
first with megavoltage imaging and more recently, kilo-
voltage imaging. Prostate patients are treated on a Varian
Trilogy (Varian Medical Systems, Palo Alto, CA) or an
Elekta SynergyS (Elekta Oncology Systems, Crawley,
UK), with the decision based on whether or not the pa-
tient is receiving lymph node irradiation. Because our
Elekta has the optional beam modulator with 4 mm wide
leaves and a maximum field size of 21 x 16 cm2, all
patients receiving lymph node irradiation are treated on
the Varian.
Prostate patients undergo CT-simulation with a vacuum
bag around the thighs and knees for immobilization, a rec-
tal marker in place and a full bladder. CT slice thickness is
1.5 mm for patients with implanted Calypso Beacons. The
prostate and proximal seminal vesicles are contoured and
combined, constitute the CTV. A uniform PTV expansionof 6 mm is added to the CTV, except posteriorly, which
has a 4 mm margin. The PTV receives 79.2 Gy in 44 frac-
tions. If pelvic lymph nodes are treated, they receive 45 Gy
in 25 fractions, after which, only the prostate and seminal
vesicles receive treatment. Patients are asked to have a full
bladder at the time of treatment, but are given no dietary
instructions. However, if at the time of CT simulation, the
patient was found to have a full or distended rectum, he
was asked to void and was re-simulated.
Both linacs have kV on-board imaging (OBI) and are
capable of performing conebeam CT (CBCT). Because
of a disparate workload on the two machines, orthogonal
kV imaging is the primary localization method on the
Trilogy. On both machines, the patient is set up on the
treatment couch by aligning the room lasers to skin
marks. CBCT or kV images are then aligned manually to
the implanted markers on the planning CT or the DRRs
from the treatment planning system. The couch shifts
are calculated based on the seed alignments and the
patient’s position is adjusted accordingly. Our therapists
have extensive experience using these technologies, as
there have been over 3200 prostate localizations in our
department since 2006.
The Calypso system uses an array of AC magnetic
coils to generate a resonant response from implanted
electromagnetic transponders (Beacons™), which is
detected by a second array of receiver coils [15]. The
array position relative to the linac isocenter is deter-
mined by three infrared cameras mounted on the ceiling
in the room. Daily quality assurance is performed each
morning and the entire system is calibrated monthly.
The Beacons (8 mm in length and 2 mm in diameter)
are implanted in the right and left base and the apex of
the prostate. The implantation is performed with trans-
rectal ultrasound guidance in a manner analogous to
gold marker implantation. The coordinates of the Bea-
cons are identified on the treatment planning CT by
carefully contouring the Beacons and having the treat-
ment planning software autoplace a point in the center
of each contoured volume. The coordinates of these
points and the isocenter are entered into the Calypso
tracking station. Similar to CBCT and kV imaging, initial
patient localization is performed using skin marks to
align with room lasers. Calypso is used to localize the
patient and the system calculates the initial offset. The
couch is shifted until the three offsets are zero. During
treatment, Calypso monitors and reports the offset be-
tween the actual and planned isocenter position at a rate
of 10 Hz. Calypso has been shown to have sub-
millimeter accuracy [15]. Additionally, Calypso
localization compares favorably to that using room
mounted kV x-ray localization of implanted radio-
opaque markers [16], with a positional stability of the
transponders that is similar to that of gold seeds [17].
Table 1 Mean localization differences for OBI-Calypso
and CBCT-Calypso (mm) comparisons and percentage of
differences≤ 3 mm
kV Imaging CBCT
Mean SD Mean SD
Vert −0.09 (95.8%) 1.40 −0.18 (86.1%) 2.90
Long 0.48 (94.3%) 1.50 −0.79 (84.5%) 2.18
Lat 0.08 (97.0%) 1.04 0.01 (96.0%) 1.20
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sessions from 21 patients and kV imaging-Calypso data
consists of 260 localizations from 6 patients. For Calypso
patients treated on the SynergyS, the CBCT is acquired
and the couch shifts are calculated using the alignment
of the Beacons to their contours from the planning sys-
tem. Prior to moving the patient, Calypso is used to ver-
ify the CBCT shifts and the patient is then shifted to the
correct position. Calypso patients treated on the Trilogy
are localized using Calypso, shifted, and then kV images
are taken. The alignment of the Calypso Beacon con-
tours in the kV images is used to confirm the Calypso
localization. In April 2010, we reduced the frequency of
radiographic imaging of Calypso patients to once per
week.
Statistical analysis
Localization differences are calculated from the couch
shifts determined by Calypso and the radiographic
localization technique. The Wilcoxon signed rank test is
used to determine if these differences are statistically sig-
nificant and p values< 0.05 were considered statistically
significant. Using the test proposed by Bland and Alt-
man [18] for comparing two measurement methods, we
plotted the difference in the couch shifts vs. the average
of the shifts to try to discern any trends in the
localization differences. If the methods are equivalent,
the mean differences should be zero and there should be
no trends observed in the data. We also calculated
Pearson’s product–moment correlation coefficient (R2)
to determine if there is a linear relationship between the
shifts determined by Calypso and the radiographic tech-
niques. Statistical analysis was performed using MatLab,
version 7.8 (The MathWorks, Natick, MA).
Results
The average difference in the CBCT-Calypso and the kV
imaging-Calypso localizations are shown in Table 1. The
radiographic and Calypso localizations agree very well,
with a difference of less than 1 mm in all directions. The
distributions of the localization error differences are
shown in Figure 1. For the combined population of
patients, there were small but statistically significant dif-
ferences (p< 0.05) in radiographic and Calypso localiza-
tions in the AP and SI directions, respectively. When the
kV imaging and CBCT patients were analyzed separ-
ately, we again observed small, but statistically signifi-
cant differences in the longitudinal and lateral directions
for kV imaging and in the vertical and longitudinal
directions for CBCT. Results of the Wilcoxon signed
rank test are found in Table 2.
Figure 2 shows the couch shifts determined from the
radiographic localizations plotted against those deter-
mined by Calypso. The plots for the kV imaging appearto lie on distinct lines due to the coarse resolution of the
OBI shifts (0.1 cm). The Pearson correlation coefficients
for the kV imaging data are 0.95, 0.89 and 0.85 in the
vertical, longitudinal and lateral directions and for the
CBCT data, are 0.71, 0.92 and 0.88, indicating a reason-
ably strong linear relationship between Calypso and the
radiographic techniques. A correlation coefficient of 1
indicates a perfect linear dependence. The Bland-Altman
plots for the vertical, lateral, and longitudinal couch
shifts are shown in Figure 3. Also plotted are the mean
difference (dashed magenta line) and the 95% limits of
agreement (dashed red lines). The mean differences and
95% limits of agreement for the kV imaging were −0.81
(−2.83, 2.67), -0.41 (−3.41, 2.59) and 0.06 (−1.97, 2.09)
mm for the vertical, longitudinal and lateral directions.
For the CBCT, the mean differences were −0.18, -0.79
and −0.01 mm and the 95% limits of agreement were
(−5.86, 1.01), (−5.06, 3.47) and (−2.37, 2.35) mm.
Discussion
The use of implanted fiducial markers and conebeam
CT has been shown to improve prostate localization and
reduce interobserver differences when compared to bony
anatomy and soft tissue alignment methods [19-21].
However, the question remains as to whether it is an im-
provement over 2D orthogonal radiographic imaging.
This study is the first to investigate all three localization
techniques and attempts to determine if there are sig-
nificant differences among the three technologies.
Ogunleye et al. [22] studied Calypso and kV imaging
differences for prostate localization and found mean dif-
ferences of 1.2 ± 0.9, 1.1 ± 0.9 and 0.7 ± 0.5 mm in the
vertical, longitudinal and lateral directions, respectively.
Their results are slightly larger than other comparisons
of Calypso and 2D radiographic imaging, which all
found sub-millimeter differences between the technolo-
gies [16,23,24]. It is unclear what caused the somewhat
larger differences in Ogunleye’s study despite their
efforts to record Calypso and kV imaging positions at
the same time.
A study analyzing Calypso-CBCT agreement found
mean differences between those technologies that were
larger than our results in the vertical and lateral direc-
tions [25]. They also found better average agreement
Figure 1 Localization difference distributions for CBCT - Calypso and kV-Imaging - Calypso comparison.
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bony anatomy in the vertical and lateral directions com-
pared to CBCT alignment to the Beacons, which is un-
usual considering the unreliable nature of bony anatomy
localization for the prostate [7,13]. However, their calcu-
lated theoretical PTV margins were larger for the bony
anatomy alignment than for the other methods.
The distribution of the localization differences is wider
for the CBCT-Calypso comparison than for the kV
imaging-Calypso comparison and the mean localization
differences are larger than those for kV imaging. These
results suggest that there is more uncertainty in aligning
fiducial markers using a 3D CBCT than in aligning them
using two orthogonal images. One possible reason for
this observation is that the Calypso localization was per-
formed after CBCT imaging, but before kV OBI im-
aging, in the respective group of patients. It is possible
that the prostate could move during CBCT reconstruc-
tion and analysis, resulting in a larger disagreement be-
tween Calypso and CBCT. Because the planar kV
imaging process is faster than that of CBCT, there is a
lower probability that the prostate will move between
localizations. It is important to note that the therapistsTable 2 P values for the Wilcoxon signed rank test.
Values less than 0.05 are considered significant
Data Set Vertical Longitudinal Lateral
Combined 0.0046 < .0001 0.220
kV orthogonal imaging 0.865 < .0001 .001
CBCT 0.0028 < .0001 0.947are not matching the fiducials directly on either the
CBCT or planar kV images, but align the Beacon contours
defined on the treatment planning CT with the Beacons in
the kV and CBCT images. These same contours were used
to determine the Beacon positions relative to the isocenter
for the electromagnetic localization, therefore any system-
atic errors due to the definition of the Beacon positions
should be present in all three techniques.
CBCT slice thickness also contributes to a greater un-
certainty inherent in CBCT localization than in 2D fidu-
cial marker localization. Owen et al. [26] found mean
differences in fiducial marker localization between MV
electronic portal imaging (EPI) and CT on rails to be as
large as 3.7 mm longitudinally in a phantom. The same
group [27] also studied fiducial marker localization using
a Varian Trilogy linear accelerator and found mean dif-
ferences of 1.5 mm in the longitudinal direction between
CBCT and kV imaging in a phantom. Since these two
results are obtained from phantom studies, the
localization differences cannot be attributed to patient
or prostate motion. In patients, they found that 88.5%,
85.4% and 100% of localizations agreed within 3 mm in
the vertical, longitudinal and lateral directions when
comparing kV imaging and CBCT. However, the kV
images were obtained approximately 10 minutes after
the CBCT, during which, the prostate may have exhib-
ited significant intrafraction motion [28]. Moseley et al.
[20] found that 95.5%, 91.3% and 99.7% of MV fiducial
localizations agreed within 3 mm with kV CBCT. In our
study, the fraction of localization differences that are less
than 3 mm in the vertical, longitudinal and lateral
Figure 2 Plots of Calypso shifts vs radiographic shifts for the CBCT (left column) and kV imaging (right column) for the vertical,
longitudinal and lateral directions.
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OBI comparison and 86.1%, 84.5% and 96% for the
Calypso-CBCT comparison. These results agree well
with the patient data from Owens et al. The largest and
most frequent disagreement between Calypso and radio-
graphic localization is in the longitudinal direction, and
the agreement is worse for CBCT than for planar kVFigure 3 Bland Altman plots of the difference in Calypso and radiogr
comparison (left column) and the Calypso-kV Imaging comparison (ri
The red dashed lines represent the 95% limits of agreement and the mageimaging, in agreement with the results of both Owens
and Moseley. The CBCT reconstruction slice thickness
in the present study is 1.0 mm, less than that of Owens
(2.5 mm) or Moseley (2.0 mm), and may explain why
our mean differences are smaller than those observed in
the earlier studies. Better resolution in the longitudinal
direction would increase the accuracy of CBCTaphic shifts vs. the mean of the shifts for the Calypso-CBCT
ght column) for the vertical, longitudinal and lateral directions.
nta dashed line is the mean.
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error in CBCT localization is the imaging artifact caused
by the fiducial markers in the prostate. In contrast to
planar kV imaging, the blurring and streaking in CBCT
images makes it more difficult to determine what consti-
tutes a good alignment with the markers in the reference
CT.
Langen et al. [19] compared marker, anatomical and
contour based registration techniques using MV CT and
found marker based registration to be more accurate
than the other techniques. They also state “Because our
patient alignments are based on fiducial marker informa-
tion, they do not differ from those that would have been
made if the fiducial markers were detected on an orthog-
onal portal image pair.” This and other studies suggest,
however, that for prostate localization, the three-
dimensional information may complicate the localization
process and introduce more uncertainty than two di-
mensional orthogonal imaging. When localizing patients
using 2D images, therapists are adjusting the match in
only two dimensions at a time and must switch to an-
other view to match the orthogonal image set. The only
image that can be used to adjust the lateral position of
the patient is the AP and likewise, only the lateral image
can be used to adjust the vertical (AP) position. A lateral
adjustment of the AP image does not affect the thera-
pist’s match of the lateral images. However, when match-
ing two 3D image sets, an adjustment in the lateral
direction immediately alters the match in the coronal
and axial registrations, leading the therapist to select a
localization that may be a compromise between perfect
matches in each of the two views.
One recent paper comparing planar kV imaging and
CBCT for the prostate found that the precision and
setup accuracy of implanted fiducial markers on 2D- 2D
and 3D images was approximately the same magnitude
[29]. Logadottir’s margin calculations from the setup
errors yielded slightly larger values for the kV imaging
than for the CBCT. A possible explanation for their re-
sult is that the kV imaging was always performed after
the CBCT was acquired, increasing the likelihood that
the prostate would be further from its localized position.
The data presented in their study supports this conclu-
sion, as the average shift in marker position increased
with an increase in time between imaging procedures.
Logadottir et al. acknowledge that it is not possible to
separate differences in accuracy from differences caused
by prostate motion, which is also a limitation of the
present analysis.
Despite highly accurate localization techniques, mar-
gin reduction is limited by intrafraction motion [13]. In
contrast to other localization technologies, Calypso has
the ability to continuously track the prostate during ra-
diation therapy. As an example, Calypso detected a7.5 mm longitudinal shift that occurred after the
localization CBCT had been obtained. This shift was
verified with a subsequent CBCT and corrected. A sep-
arate group of patients treated on our SBRT prostate
protocol receive a CBCT prior to and in the middle of
treatment. Based on matching of implanted gold seeds,
the intrafraction CBCT routinely detects shifts of 3 –
5 mm, underscoring the inadequacy of a snapshot
localization at the beginning of treatment. Noel et al.
[30] concluded that intermittent imaging is not sufficient
for accurately predicting intrafraction motion between
the two images.
Conclusions
In patient localizations with both CBCT/kV imaging and
the Calypso system, the average localization differences
are less than 0.8 mm, indicating excellent agreement.
Each of the three localization methods is accurate and
suitable for high-precision prostate localization.
The additional volumetric information provided by
CBCT is generally believed to be beneficial to patient
localization. For example, in addition to localizing the
prostate, CBCT provides information about the shape
and location of organs at risk such as the bladder and
rectum that other modalities do not. From a CBCT,
therapists and physicians can quickly determine whether
or not the patient has followed the pre-treatment blad-
der preparation instructions. For patients treated with a
rectal balloon in place, a CBCT is necessary to check the
volume and positioning of the balloon. We have demon-
strated that there is more uncertainty in localizing the
prostate with conebeam CT than with orthogonal kV
images, though it is our opinion that the small increase
in uncertainty in the prostate position with CBCT is not
clinically significant and does not outweigh the useful-
ness of the extra anatomical information provided by
volumetric imaging.
Calypso is unique in that it is the only localization
method for prostate patients that does not require
matching an acquired image with a reference, potentially
resulting in more accurate localization without additional
dose to the patient. However, it provides no information
about the target itself or organs at risk.
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